Current Portfolio
OxThera
Developing treatments for patients with hyperoxaluria.
Key Facts
- Sector
Life Sciences
- Country
Sweden
- Fund
LSP 5
- Entry
2016
Website

Do You Want to Know More?
We are eager to explore how we can achieve great things together.
Developing treatments for patients with hyperoxaluria.
Life Sciences
Sweden
LSP 5
2016
Website
We are eager to explore how we can achieve great things together.